We found an association between high tumor expression of DNMT1 and shorter OS, concordant with previous studies in which high expression of DNMT1 was associated with poor prognosis in malignant lymphoma [10], renal cell carcinoma [18], pancreatic cancer [19], and bladder cancer [20]. Here, DNMT1 is linked to familial pancreatic carcinoma.